Lamotrigine Tablet, Film Coated, Extended Release
Product Images NDC 69117-0045

Product Visual Gallery

This gallery contains 27 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 69117-0045). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Yiling Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100 mg Tab (100mg Picture)

The image shows a round, white, film-coated extended-release tablet labeled with the imprint 'Y33'. This is consistent with lamotrigine extended-release tablets produced by Yiling Pharmaceutical, Inc. The exact strength is not visible in the image provided.*

FDA Label Image

200 mg Tab (200mg Picture)

The image shows an embossed marking on a film-coated tablet with the imprint 'Y34'. This tablet corresponds to lamotrigine extended-release, produced by Yiling Pharmaceutical, Inc. The imprint 'Y34' helps identify the specific strength and formulation among the available dosages.*

FDA Label Image

250 mg Tab (250mg Picture)

Lamotrigine extended-release tablet imprinted with 'Y35'. The film-coated, oval-shaped tablet is for oral administration and comes in various strengths, including 100 mg, manufactured by Yiling Pharmaceutical, Inc.*

FDA Label Image

25 mg Tab (25mg Picture)

The image shows a round, white film-coated extended-release tablet imprinted with "Y31." This is a lamotrigine tablet, available in various strengths including 100 mg, manufactured by Yiling Pharmaceutical, Inc.*

FDA Label Image

300 mg Tab (300mg Picture)

Film-coated, extended-release oral tablet imprinted with 'Y36'. The tablet is white and oval-shaped. It corresponds to lamotrigine extended-release, a prescription drug by Yiling Pharmaceutical, Inc.*

FDA Label Image

50 mg Tab (50mg Picture)

The image shows a round, white, film-coated extended-release tablet identified by the imprint "Y32". The tablet is from the lamotrigine product family, which includes various strengths such as 25 mg, 50 mg, 100 mg, 200 mg, 250 mg, and 300 mg. It is labeled by Yiling Pharmaceutical, Inc. for oral administration.*

FDA Label Image

Figure 1. Proportion Of Patients By Responder Rate For Lamotrigine And Placebo Group (primary Generalized Tonic-clonic Seizures Study) (Figure 1)

A responder rate cumulative distribution curve comparing lamotrigine extended-release and placebo across percent of patients. The Y-axis represents responder rate from worsening to improvement, while the X-axis shows percent of patients. Two lines depict responder rates for lamotrigine (solid line, N=70) and placebo (dashed line, N=73).*

FDA Label Image

Figure 2. Proportion Of Patients By Responder Rate For Lamotrigine And Placebo Group (partial-onset Seizure Study) (Figure 2)

A line graph depicting responder rates for lamotrigine extended-release tablets versus placebo. The y-axis shows responder rate ranging from worsening to improvement, and the x-axis shows percent of patients from 0 to 100. Two lines compare responder rates for lamotrigine (solid line, N=116) and placebo (dashed line, N=120) across patient percentages.*

FDA Label Image

Chemical Structure (Graphic 01)

Chemical structure of lamotrigine, showing a chlorinated phenyl ring attached to a triazine ring with amine groups.*

FDA Label Image

25mg 30tablets (Label 01)

Label for Lamotrigine Extended-Release Tablets USP 25 mg oral tablets, 30 count, manufactured by Yiling Pharmaceutical Ltd and distributed by Yiling Pharmaceutical, Inc. The label includes storage instructions, a barcode, and cautionary information about product dispensing and safety seal.*

FDA Label Image

25mg 100tablets (Label 02)

The label is for Lamotrigine Extended-Release Tablets USP, 25 mg strength, produced by Yiling Pharmaceutical Ltd and distributed by Yiling Pharmaceutical, Inc. The oral film-coated tablets come in a bottle containing 100 tablets. The label includes manufacturer and distributor addresses, storage instructions, a barcode, and warnings about verifying product integrity and dispensing medication guides. The NDC is 69117-0044-2.*

FDA Label Image

25mg 500tablets (Label 03)

Lamotrigine Extended-Release Tablets USP 25 mg film-coated tablets packaging label showing dosage form and strength. The label indicates 500 tablets per container, manufactured by Yiling Pharmaceutical Ltd, China, and distributed by Yiling Pharmaceutical, Inc., USA. Storage instructions and safety warnings about the printed safety seal under the cap are also included.*

FDA Label Image

50mg 30tablets (Label 04)

Lamotrigine Extended-Release Tablets, USP 50 mg film-coated tablets in a 30-tablet bottle label by Yiling Pharmaceutical, Inc. The label includes manufacturer and distributor information, a barcode, dosage form, strength, and storage instructions. The tablet depicted is round and beige with the imprint 'Y32.'*

FDA Label Image

50mg 100tablets (Label 05)

Lamotrigine extended-release tablets, USP 50 mg, film-coated, oral dosage form. The label shows the product name, strength, and dosage once a day, with a round beige tablet imprinted with 'Y32'. It indicates the product is by Yiling Pharmaceutical, Ltd (manufacturer China) and Yiling Pharmaceutical, Inc. (distributor USA). Packaging contains 100 tablets. Storage and safety instructions are included.*

FDA Label Image

50mg 500tablets (Label 06)

Lamotrigine Extended-Release Tablets, USP 50 mg film-coated tablets label showing manufacturer Yiling Pharmaceutical Ltd, China, and distributor Yiling Pharmaceutical, Inc., Las Vegas, NV. The label includes dosage strength 50 mg, quantity 500 tablets, NDC 69117-0045-3, storage instructions, and caution to verify product dispensed and dispense accompanying medication guide. The label also features a barcode and the Yiling logo.*

FDA Label Image

100mg 30tablets (Label 07)

Label for lamotrigine extended-release tablets, USP 100 mg, oral film-coated tablets by Yiling Pharmaceutical, Inc. The label features dosing instructions as once a day, package count of 30 tablets, and storage conditions. Includes manufacturer and distributor addresses in China and USA, barcode, and safety warnings about the printed safety seal under the cap.*

FDA Label Image

100mg 100tablets (Label 08)

Label for Lamotrigine Extended-Release Tablets, USP 100 mg film-coated oral tablets by Yiling Pharmaceutical, Inc. The label includes the 100 mg strength, an image of the round orange tablet marked Y33, barcode, manufacturer and distributor addresses, storage instructions, and a note to dispense the accompanying medication guide. Package contains 100 tablets.*

FDA Label Image

100mg 500tablets (Label 09)

Lamotrigine Extended-Release Tablets, USP 100 mg film-coated tablets label by Yiling Pharmaceutical, Inc. It includes manufacturer and distributor addresses, NDC 69117-0046-3, and storage instructions. The label indicates a bottle containing 500 tablets, with dosing guidance to take once a day and cautions to verify the product dispensed and include the medication guide.*

FDA Label Image

200mg 30tablets (Label 10)

Label for Lamotrigine Extended-Release Tablets, USP 200 mg, oral film-coated tablets by Yiling Pharmaceutical, Inc. The label includes dosage form, strength, quantity of 30 tablets, storage instructions, and cautions about verifying the product and safety seal. Manufacturer and distributor addresses in China and the USA are shown, along with a round blue tablet imprint Y34.*

FDA Label Image

200mg 100tablets (Label 11)

Lamotrigine Extended-Release Tablets, USP 200 mg film-coated tablets in a 100-count package, labeled for once daily oral use. The manufacturer is Yiling Pharmaceutical Ltd, China, with distributor Yiling Pharmaceutical, Inc., Las Vegas, USA. The label includes storage instructions and a safety warning about the seal.*

FDA Label Image

200mg 500tablets (Label 12)

Lamotrigine Extended-Release Tablets USP 200 mg film-coated tablet label from Yiling Pharmaceutical, Inc. The label includes dosage strength, a blue pill imprint 'Y34', manufacturer and distributor addresses, barcode, storage instructions, and caution to verify product and dispense medication guide. Package size indicated as 500 tablets.*

FDA Label Image

250mg 30tablets (Label 13)

Lamotrigine Extended-Release Tablets, USP 250 mg film-coated tablets in a pack of 30, manufactured by Yiling Pharmaceutical Ltd and distributed by Yiling Pharmaceutical, Inc. The tablet is oblong with imprint "Y35". The label includes storage instructions and a caution to verify the product dispensed and to dispense the accompanying medication guide.*

FDA Label Image

250mg 100tablets (Label 14)

Label for lamotrigine extended-release tablets, USP 250 mg, film-coated oral tablets supplied in a package of 100 tablets. Manufactured by Yiling Pharmaceutical Ltd, China, and distributed by Yiling Pharmaceutical, Inc., USA. The label includes dosage strength, a tablet image marked Y35, dosing frequency (once a day), storage instructions, cautions, barcode, and NDC 69117-0048-2.*

FDA Label Image

250mg 500tablets (Label 15)

Label for Lamotrigine Extended-Release Tablets USP 250 mg by Yiling Pharmaceutical Ltd. The label includes manufacturer and distributor addresses, dosage form as extended-release film-coated tablets, and a tablet image marked Y35. It specifies 500 tablets per container, storage instructions, a caution to verify the product dispensed, and a notice about the safety seal under the cap.*

FDA Label Image

300mg 30tablets (Label 16)

Lamotrigine Extended-Release Tablets, USP 300 mg oral tablets, film coated, once daily. The label shows a white oval tablet imprinted with Y36. Manufactured by Yiling Pharmaceutical Ltd, China, and distributed by Yiling Pharmaceutical, Inc., Las Vegas, NV, USA. Package contains 30 tablets with caution and storage instructions.*

FDA Label Image

300mg 100tablets (Label 17)

Label for Lamotrigine Extended-Release Tablets, USP 300 mg by Yiling Pharmaceutical, Inc. The label shows the product is an oral extended-release film-coated tablet, packaged as 100 tablets. The label includes storage instructions, manufacturer's and distributor's addresses, and a tablet imprint "Y36" image. It also contains warnings about the safety seal and advises dispensing a medication guide with the product.*

FDA Label Image

300mg 500tablets (Label 18)

Label for Lamotrigine Extended-Release Tablets, USP 300 mg by Yiling Pharmaceutical, Inc. The label indicates the medication is oral, film-coated, extended-release tablets, dispensed as 500 tablets per container. It includes storage instructions and a caution to verify the product dispensed and to dispense the accompanying medication guide. The label features the NDC 69117-0049-3 and the manufacturer's and distributor's contact information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.